-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Tenofovir amibufenamide
Category | Hepatitis B Virus (HBV) |
CAS | 1571076-26-0 |
Description | Tenofovir amibufenamide, a prodrug of Tenofovir, is an orally active antiviral agent. It inhibits HBV and can be used in the study of chronic hepatitis B (CHB). |
Product Information
Synonyms | HS-10234; Alanine, N-[(S)-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl]-2-methyl-, 1-methylethyl ester; Isopropyl 2-(((S)-((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)amino)-2-methylpropanoate |
IUPAC Name | propan-2-yl 2-[(S)-[[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-phenoxyphosphoryl]amino]-2-methylpropanoate |
Molecular Weight | 490.49 |
Molecular Formula | C22H31N6O5P |
Canonical SMILES | CC(C)OC(=O)C(C)(C)NP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OC3=CC=CC=C3 |
InChI | InChI=1S/C22H31N6O5P/c1-15(2)32-21(29)22(4,5)27-34(30,33-17-9-7-6-8-10-17)14-31-16(3)11-28-13-26-18-19(23)24-12-25-20(18)28/h6-10,12-13,15-16H,11,14H2,1-5H3,(H,27,30)(H2,23,24,25)/t16-,34-/m1/s1 |
InChIKey | ORHSFGJQGPUCRR-JTJFVBHCSA-N |
Purity | 99.38% |
Solubility | Soluble in DMSO |
Appearance | Solid Powder |
Storage | Store at 2-8°C for short term (days to weeks) or -20°C for long term (months to years) |
Complexity | 720 |
Exact Mass | 490.20935511 |
Target | HBV |
XLogP3-AA | 2.1 |